OGT Launches Nine New High-Intensity Cytocell Aquarius FISH Probes

Oxford Gene Technology (OGT), The Molecular Genetics Company, has further expanded its extensive catalogue of fluorescence in-situ hybridisation (FISH) products with nine new Cytocell Aquarius probes.

The range now includes ETV6 Proximal Probe Green, ETV6 Distal Probe Red, MPO Probe Red, TP53 Probe Green, NUP214 Probe Red, DEK Probe Green, TAS2R1 (5p15.31) Probe Green, Chromosome 9 Satellite III Probe Aqua, and Chromosome 15 Alpha Satellite Probe Red. These cost-effective and quality-assured probes produce specific, high-intensity signals with excellent contrast and minimal background for the utmost confidence in results. Optimised for use on common sample types, the probes are also pre-mixed in hybridisation buffer, increasing ease of use and reducing errors in the laboratory.
 
Highlighting OGT’s renowned customer service, the new additions to the range have been developed in response to high customer demand via the Cytocell myProbes FISH probes service. This custom probe design and manufacturing service enables OGT customers to purchase unique, fully quality-assured FISH probes for virtually any sequence in the entire human genome using the proprietary Cytocell BAC clone collection.
 
“These new probes are a real testament to the way OGT listens and responds to customer needs. We had a lot of people requesting these genes via our myProbes service so we wanted to make them readily available,” said Faidra Partheniou, Haematology product manager at OGT. “Our customer support also ensures that we’re consistently there for our customers with expert advice and evaluation support. OGT offers the largest portfolio of FISH probes available and we look forward to announcing further new probes in the near future.”
 
The new additions to the Cytocell Aquarius probe range are currently only available within North America as analyte specific reagents (ASRs), analytical and performance characteristics are not established. CE-marked IVD versions for sale in Europe are anticipated.
 
Oxford Gene Technology (OGT) provides genetics research solutions to clinical and academic research institutions. Founded by Professor Sir Edwin Southern, and with customers in more than 60 countries worldwide, OGT is increasing its share in the genomic medicine market. The United Kingdom-based company’s Cytocell, CytoSure, and SureSeq range of fluorescence in-situ hybridisation (FISH), microarray and next generation sequencing (NGS) products deliver high-quality genetic analysis, enabling accurate identification and confirmation of the causative variation underlying genetic disease.